A Fifth Circuit ruling that keeps mifepristone available, but curtails access to it, is the newest front in a battle over the FDA’s power to approve medications.



Read the story here.

A Fifth Circuit ruling that keeps mifepristone available, but curtails access to it, is the newest front in a battle over the FDA’s power to approve medications.
 
Read the story <a href="https://www.wired.com/story/abortion-pill-mifepristone-ruling-drug-access/">here</a>.

Get in-depth coverage of current and future trends in technology, and how they are shaping business, entertainment, communications, science, politics, and society.

Advertisement